Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Price:
59.11 CNY
-0.94%
Market Closed
Updated:
May 5, 2024
Hangzhou Tigermed Consulting Co Ltd
Net Income (Common)
|
Hangzhou Tigermed Consulting Co Ltd
Net Income (Common) Peer Comparison
Comparables:
603259
300759
2269
1548
M
688114
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Net Income (Common)
-$95.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Net Income (Common)
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Hangzhou Tigermed Consulting Co Ltd's Net Income (Common)?
Net Income (Common)
2B
CNY
2B
CNY
Based on the financial report for Dec 31, 2023, Hangzhou Tigermed Consulting Co Ltd's Net Income (Common) amounts to 2B CNY.
What is Hangzhou Tigermed Consulting Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
36%
36%
Over the last year, the Net Income (Common) growth was 1%. The average annual Net Income (Common) growth rates for Hangzhou Tigermed Consulting Co Ltd have been 5% over the past three years , 34% over the past five years , and 36% over the past ten years .
You don't have any saved screeners yet
